AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 166 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $174,120 | +386833.3% | 152,737 | +311608.2% | 0.00% | – |
| Q2 2023 | $45 | +66.7% | 49 | 0.0% | 0.00% | – |
| Q1 2023 | $27 | -93.6% | 49 | -93.3% | 0.00% | – |
| Q4 2022 | $419 | -97.2% | 726 | -98.4% | 0.00% | – |
| Q3 2022 | $15,000 | -61.5% | 46,623 | -57.7% | 0.00% | – |
| Q2 2022 | $39,000 | -89.4% | 110,287 | -78.5% | 0.00% | – |
| Q1 2022 | $367,000 | -82.5% | 511,790 | -44.7% | 0.00% | -100.0% |
| Q4 2021 | $2,093,000 | +62.0% | 926,186 | +106.4% | 0.00% | 0.0% |
| Q3 2021 | $1,292,000 | -62.6% | 448,643 | -50.8% | 0.00% | -50.0% |
| Q2 2021 | $3,459,000 | -9.9% | 912,768 | -19.5% | 0.00% | 0.0% |
| Q1 2021 | $3,840,000 | +3022.0% | 1,134,548 | +2488.7% | 0.00% | – |
| Q4 2020 | $123,000 | +215.4% | 43,827 | +182.9% | 0.00% | – |
| Q3 2020 | $39,000 | -99.5% | 15,492 | -97.5% | 0.00% | -100.0% |
| Q2 2020 | $8,258,000 | +1009.9% | 608,097 | +519.7% | 0.01% | +500.0% |
| Q1 2020 | $744,000 | +59.7% | 98,129 | +32.9% | 0.00% | – |
| Q4 2019 | $466,000 | -64.0% | 73,842 | -77.6% | 0.00% | -100.0% |
| Q3 2019 | $1,295,000 | -23.3% | 330,179 | -5.3% | 0.00% | 0.0% |
| Q2 2019 | $1,689,000 | +268.8% | 348,834 | +524.3% | 0.00% | – |
| Q1 2019 | $458,000 | -73.8% | 55,872 | -82.3% | 0.00% | -100.0% |
| Q4 2018 | $1,748,000 | +284.2% | 316,042 | +513.5% | 0.00% | – |
| Q3 2018 | $455,000 | +2.5% | 51,517 | +15.9% | 0.00% | – |
| Q2 2018 | $444,000 | +29.8% | 44,465 | +24.0% | 0.00% | – |
| Q1 2018 | $342,000 | -45.6% | 35,859 | -15.2% | 0.00% | -100.0% |
| Q4 2017 | $629,000 | +17.1% | 42,272 | +54.8% | 0.00% | – |
| Q3 2017 | $537,000 | +842.1% | 27,301 | +586.0% | 0.00% | – |
| Q2 2017 | $57,000 | +1800.0% | 3,980 | +1136.0% | 0.00% | – |
| Q1 2017 | $3,000 | -96.8% | 322 | -96.4% | 0.00% | – |
| Q4 2016 | $94,000 | – | 9,066 | +36164.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 25 | -99.7% | 0.00% | – |
| Q2 2016 | $61,000 | -70.7% | 8,119 | -64.9% | 0.00% | – |
| Q1 2016 | $208,000 | +71.9% | 23,110 | +147.1% | 0.00% | – |
| Q4 2015 | $121,000 | +1628.6% | 9,352 | +1217.2% | 0.00% | – |
| Q3 2015 | $7,000 | -83.3% | 710 | -82.4% | 0.00% | – |
| Q2 2015 | $42,000 | +23.5% | 4,040 | +30.3% | 0.00% | – |
| Q1 2015 | $34,000 | -47.7% | 3,100 | -44.8% | 0.00% | – |
| Q4 2014 | $65,000 | +983.3% | 5,616 | +1891.5% | 0.00% | – |
| Q3 2014 | $6,000 | +100.0% | 282 | +166.0% | 0.00% | – |
| Q2 2014 | $3,000 | – | 106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |